BINCY KAPPEN: Open Payments
NPI 1477222347 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$681 in 26 payments from 12 companies in 2025. Trend: 2023 $2,031 · 2024 $1,385 · 2025 $681
Food & beverage: $681
| Company | Payments | Amount |
|---|---|---|
| Travere Therapeutics, Inc. | 13 | $355 |
| Novo Nordisk Inc | 3 | $62 |
| SHIELD THERAPEUTICS INC | 1 | $51 |
| Mallinckrodt Hospital Products Inc. | 1 | $33 |
| Alexion Pharmaceuticals, Inc. | 1 | $32 |
| ANI Pharmaceuticals, Inc. | 1 | $26 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| Fresenius USA Marketing, Inc. | 1 | $23 |
| Amgen Inc. | 1 | $21 |
| Pharmacosmos Therapeutics Inc. | 1 | $21 |
Products named: ACCRUFER, TERLIVAZ, ULTOMIRIS, PURIFIED CORTROPHIN GEL, FARXIGA, VELPHORO, Wegovy, KRYSTEXXA.
Industry payments across OK — which companies pay providers there.
